{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:47:00Z","timestamp":1758980820280,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.annder.2012.07.001","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T14:15:39Z","timestamp":1344867339000},"page":"515-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leishmaniose cutan\u00e9e\u00a0: peut-on d\u00e9terminer l\u2019esp\u00e8ce infectante sur la seule clinique\u00a0?"],"prefix":"10.1016","volume":"139","author":[{"given":"P.","family":"Buffet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2012.07.001_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/clinids\/20.3.542","article-title":"Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269\u00a0patients presenting to a tropical disease unit","volume":"20","author":"Caumes","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0010","first-page":"383","article-title":"Cutaneous leishmaniasis in France: towards the end of injectable therapy?","volume":"96","author":"Buffet","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.annder.2012.07.001_bib0015","first-page":"503","article-title":"Traitement des leishmanioses cutan\u00e9es localis\u00e9es","volume":"121","author":"Buffet","year":"1994","journal-title":"Ann Dermatol Venerol"},{"key":"10.1016\/j.annder.2012.07.001_bib0020","doi-asserted-by":"crossref","unstructured":"Buffet PA, Rosenthal E, Gangneux JP, Lightburne E, Couppie P, Morizot G, et al. Therapy of leishmaniasis in France: consensus on proposed guidelines. Presse Med 40:173\u2013184.","DOI":"10.1016\/j.lpm.2010.09.023"},{"key":"10.1016\/j.annder.2012.07.001_bib0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0030","doi-asserted-by":"crossref","unstructured":"Aoun K, Ben Abda I, Bousslimi N, Bettaieb J, Siala E, Ben Abdallah R, et al. Caract\u00e9risation comparative des trois formes de leishmaniose cutan\u00e9e end\u00e9miques en Tunisie. Doi: 10.1016\/j.annder.2012.04.154.","DOI":"10.1016\/j.annder.2012.04.154"},{"key":"10.1016\/j.annder.2012.07.001_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/136485905X19874","article-title":"Cutaneous leishmaniasis in Tunisia: results of the iso-enzymatic characterization of 71\u00a0strains","volume":"99","author":"Kallel","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2012.07.001_bib0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/165.3.518","article-title":"The natural history of cutaneous leishmaniasis in Guatemala","volume":"165","author":"Herwaldt","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/vbz.2008.0126","article-title":"The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France","volume":"9","author":"Dereure","year":"2009","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0050","doi-asserted-by":"crossref","unstructured":"Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 15:19505.","DOI":"10.2807\/ese.15.10.19505-en"},{"key":"10.1016\/j.annder.2012.07.001_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tmaid.2004.11.002","article-title":"Clinical features and diagnosis of 42\u00a0travellers with cutaneous leishmaniasis","volume":"4","author":"Scarisbrick","year":"2006","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0060","unstructured":"WHO. Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the control of leishmaniases, Geneva, 22-26\u00a0March 2010. WHO Technical Report series. 2011 949:1\u2013185."},{"key":"10.1016\/j.annder.2012.07.001_bib0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0959-8049(93)90177-H","article-title":"Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study","volume":"29A","author":"Verweij","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annder.2012.07.001_bib0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medmal.2004.07.032","article-title":"Glucantime injection: benefit versus toxicity","volume":"35","author":"Masmoudi","year":"2005","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.annder.2012.07.001_bib0075","unstructured":"Ezzine Sebai N, Mrabet N, Khaled A, Zeglaoui F, Kharfi M, Fazaa B, et al. Side effects of meglumine antimoniate in cutaneous leishmaniasis: 15\u00a0cases. Tunis Med 88:9\u201311."},{"key":"10.1016\/j.annder.2012.07.001_bib0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4269\/ajtmh.2009.80.939","article-title":"Drug hypersensitivity syndrome induced by meglumine antimoniate","volume":"80","author":"Jeddi","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2012.07.001_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2007.76.48","article-title":"Healing of Old World cutaneous leishmaniasis in travellers treated with fluconazole: drug effect or spontaneous evolution?","volume":"76","author":"Morizot","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2012.07.001_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","volume":"27","author":"el-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.07.001_bib0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin","volume":"85","author":"Grogl","year":"1999","journal-title":"J Parasitol"},{"key":"10.1016\/j.annder.2012.07.001_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2012.07.001_bib0105","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL\/6\u00a0Model","volume":"1","author":"Lecoeur","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0110","article-title":"Early curative applications of aminoglycosides (WR279396) on experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity","author":"Lecoeur","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.annder.2012.07.001_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-6-3","article-title":"Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis","volume":"6","author":"Modabber","year":"2007","journal-title":"Kinetoplastid Biol Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0120","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2012.07.001_bib0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812004954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812004954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:59:10Z","timestamp":1758970750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963812004954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0151963812004954"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2012.07.001","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmaniose cutan\u00e9e\u00a0: peut-on d\u00e9terminer l\u2019esp\u00e8ce infectante sur la seule clinique\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2012.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}